Application of Continuous Renal Replacement Therapy (CRRT) in Patients with Severe Acute Pancreatitis: An Analytical Study

Abstract Purpose Exploring the correlation between Continuous Renal Replacement Therapy (CRRT) and the prognostic outcomes of patients with Severe Acute Pancreatitis (SAP); analyzing the impact of CRRT initiation time on the final prognosis of SAP patients; evaluating factors affecting the therapeutic effect of CRRT in SAP patients without strong indications for CRRT, and developing a multi-factorial predictive model for the efficacy of CRRT in treating SAP. Methods This retrospective cohort study analyzed clinical data from severe acute pancreatitis (SAP) patients admitted to The Affiliated LiHuili Hospital of Ningbo University (2015–2024), collecting baseline characteristics (demographics, disease severity scores), CRRT parameters (initiation timing, laboratory values), and clinical outcomes. Patients were stratified by prognosis and CRRT status, with subgroup analyses performed for CRRT-treated cases. After excluding patients with definitive CRRT indications, we randomly allocated cases to training (80%) and validation (20%) sets. Using logistic regression, we identified CRRT failure predictors, evaluated their predictive value via ROC analysis, and developed/validated a nomogram prediction model. Results Among 563 initially screened SAP patients, 282 were included after exclusions. (1) Prognosis analysis revealed significant differences between improved and poor prognosis groups in age, pancreatitis type, CRRT use, APACHE II and Marshall scores (all P < 0.05). Multivariate analysis identified CRRT as an independent protective factor and Marshall score as a risk factor. Compared to non-CRRT patients, CRRT-treated patients showed significantly shorter hospitalization and vasopressor duration (P < 0.05), with comparable costs. (2) In CRRT-treated patients (with/without strong indications), earlier CRRT initiation (< 36h) correlated with better outcomes (P < 0.05). Multivariate analysis confirmed CRRT initiation time as an independent prognostic factor (optimal cutoff: 36h). (3) Among 114 CRRT-treated patients without strong indications (91 in training set), significant differences existed in pancreatitis type, APACHE II, Marshall score, lactate, calcium, albumin, PT and PCT (P < 0.05). Multivariate analysis identified APACHE II, PCT and lactate as independent risk factors, and calcium/albumin as protective factors for CRRT failure. The combined model showed excellent predictive value (AUC = 0.912, 95%CI:0.841–0.982). The nomogram demonstrated good calibration in both training and test sets. Conclusions CRRT serves as an independent protective factor against poor outcomes (voluntary discharge/death) in SAP patients, while simultaneously reducing hospitalization duration and vasopressor requirements without increasing financial burden. Early application (within 36 hours) demonstrates greater therapeutic benefit. The developed nomogram prediction model, incorporating key prognostic factors, exhibits excellent clinical applicability and provides an objective basis for evaluating treatment timing in patients without strong CRRT indications.